Amgen (AMGN) Other Non-Current Assets (2009 - 2026)

Amgen's Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $12.8 billion for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 12.05% year-over-year to $12.8 billion; the TTM figure through Mar 2026 stood at $12.8 billion (up 12.05% YoY), while the FY2025 annual figure was $12.7 billion, up 27.49% from the prior year.
• Other Non-Current Assets was $12.8 billion for Q1 2026 at Amgen, up from $12.7 billion in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $13.2 billion in Q3 2025 to a low of $5.9 billion in Q4 2022.
• Historically, Other Non-Current Assets has averaged $9.2 billion across 5 years, with a median of $9.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets fell 9.58% in 2022, then jumped 62.93% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $5.9 billion in 2022, then surged by 62.93% to $9.6 billion in 2023, then advanced by 3.32% to $9.9 billion in 2024, then advanced by 27.49% to $12.7 billion in 2025, then grew by 0.79% to $12.8 billion in 2026.
• The last three Other Non-Current Assets figures came in at $12.8 billion (Q1 2026), $12.7 billion (Q4 2025), and $13.2 billion (Q3 2025), per Business Quant data.